Correlation Between Vaccinex and Surrozen
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Surrozen, you can compare the effects of market volatilities on Vaccinex and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Surrozen.
Diversification Opportunities for Vaccinex and Surrozen
Very weak diversification
The 3 months correlation between Vaccinex and Surrozen is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Vaccinex i.e., Vaccinex and Surrozen go up and down completely randomly.
Pair Corralation between Vaccinex and Surrozen
Given the investment horizon of 90 days Vaccinex is expected to under-perform the Surrozen. In addition to that, Vaccinex is 1.25 times more volatile than Surrozen. It trades about -0.08 of its total potential returns per unit of risk. Surrozen is currently generating about 0.02 per unit of volatility. If you would invest 1,985 in Surrozen on November 2, 2024 and sell it today you would lose (778.00) from holding Surrozen or give up 39.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.75% |
| Values | Daily Returns |
Vaccinex vs. Surrozen
Performance |
| Timeline |
| Vaccinex |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Surrozen |
Vaccinex and Surrozen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Surrozen
The main advantage of trading using opposite Vaccinex and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
| Surrozen vs. Bolt Biotherapeutics | Surrozen vs. Larimar Therapeutics | Surrozen vs. Keros Therapeutics | Surrozen vs. Kezar Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets |